- Home
- MKTW vs LGVN Comparison
MKTW vs LGVN Comparison
Compare MKTW & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- LGVN
- Stock Information
- Founded
- MKTW 1999
- LGVN 2014
- Country
- MKTW United States
- LGVN United States
- Employees
- MKTW N/A
- LGVN N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- MKTW Technology
- LGVN Health Care
- Exchange
- MKTW Nasdaq
- LGVN Nasdaq
- Market Cap
- MKTW 23.1M
- LGVN 25.2M
- IPO Year
- MKTW N/A
- LGVN 2021
- Fundamental
- Price
- MKTW $0.59
- LGVN $1.56
- Analyst Decision
- MKTW Hold
- LGVN Strong Buy
- Analyst Count
- MKTW 1
- LGVN 3
- Target Price
- MKTW $2.00
- LGVN $8.67
- AVG Volume (30 Days)
- MKTW 296.4K
- LGVN 164.5K
- Earning Date
- MKTW 03-06-2025
- LGVN 02-28-2025
- Dividend Yield
- MKTW 10.09%
- LGVN N/A
- EPS Growth
- MKTW N/A
- LGVN N/A
- EPS
- MKTW 0.13
- LGVN N/A
- Revenue
- MKTW $423,378,000.00
- LGVN $1,852,000.00
- Revenue This Year
- MKTW N/A
- LGVN $208.32
- Revenue Next Year
- MKTW N/A
- LGVN $43.96
- P/E Ratio
- MKTW $4.46
- LGVN N/A
- Revenue Growth
- MKTW N/A
- LGVN 141.46
- 52 Week Low
- MKTW $0.46
- LGVN $0.77
- 52 Week High
- MKTW $2.12
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- MKTW 50.07
- LGVN 45.58
- Support Level
- MKTW $0.59
- LGVN $1.53
- Resistance Level
- MKTW $0.69
- LGVN $1.71
- Average True Range (ATR)
- MKTW 0.04
- LGVN 0.13
- MACD
- MKTW -0.00
- LGVN 0.02
- Stochastic Oscillator
- MKTW 29.56
- LGVN 38.30
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.